Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Regulus Therapeutics Inc. (RGLS)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  0.00.010.06.80.10.11.220.8
            Revenue growth   -100.0%46.5%9388.9%0.0%-94.0%-94.2%170.7%
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.00.010.06.80.10.11.220.8
            Gross margin    100.0%100.0%100.0%100.0%100.0%100.0%
Selling, general and administrative   [+]9.810.08.811.312.917.018.419.1
Research and development  18.417.815.312.334.053.264.356.4
EBITDA   [+]-28.1-27.4-13.7-15.9-44.5-67.6-79.2-53.2
            EBITDA margin    -136.8%-232.8%-61806.9%-93898.6%-6635.3%-256.1%
Depreciation  0.00.40.40.92.22.42.21.5
EBITA  -28.1-27.7-14.1-16.8-46.7-70.0-81.4-54.7
            EBITA margin    -140.5%-246.4%-64809.7%-97265.3%-6817.6%-263.3%
Amortization of intangibles  0.10.10.1 0.10.10.10.1
EBIT   [+]-28.2-27.8-14.2-16.8-46.8-70.1-81.5-54.8
            EBIT margin    -141.5%-246.4%-64948.6%-97404.2%-6826.0%-263.8%
Interest expense  0.70.91.82.12.32.71.20.1
Other income (expense), net  0.60.90.20.40.50.80.8-1.0
Pre-tax income  -28.3-27.8-15.7-18.6-48.6-72.1-81.8-55.8
Income taxes  0.00.00.00.00.1-0.20.00.0
            Tax rate    0.0%  0.3%0.0%0.0%
Net income  -28.3-27.8-15.7-18.6-48.7-71.9-81.8-55.7
            Net margin    -157.2%-272.1%-67651.4%-99868.1%-6853.9%-268.5%
   
Basic EPS   [+]($1.86)($3.24)($0.45)($1.08)($5.59)($11.47)($18.59)($1.08)
Diluted EPS   [+]($1.86)($3.24)($0.45)($1.08)($5.59)($11.47)($18.59)($1.08)
   
Shares outstanding (basic)   [+]15.38.635.017.38.76.34.451.4
Shares outstanding (diluted)   [+]15.38.635.017.38.76.34.451.4
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy